AIMS: Relevant and easily accessible drug information at point-of-care is essential for physicians' decision making when prescribing. However, the information available by using Clinical Decision Support Systems (CDSSs) often does not meet physicians' requirements. The Summary of Product Characteristics (SmPC) is statutory information about drugs. However, the current structure, content and format of SmPCs make it difficult to incorporate them into CDSSs and link them to relevant patient information from the Electronic Health Records. The aim of the study was to evaluate the perceived needs for drug information among physicians in Sweden. METHODS: We recruited three focus group discussions with 18 physicians covering different specialities. The information from the groups was combined with a questionnaire administered at the beginning of the group discussions. RESULTS: Physicians reported their needs for knowledge databases at the point of drug prescribing. This included more consistent information about existing and new drugs. They also wished to receive automatically generated alerts for severe drug-drug interactions and adverse effects, and to have functions for calculating glomerular filtration rate to enable appropriate dose adjustments to be made for elderly patients and those with impaired renal function. Additionally, features enhancing electronic communication with colleagues and making drug information more searchable were suggested. CONCLUSIONS: The results from the current study showed the need for knowledge databases which provide consistent information about new and existing drugs. Most of the required information from physicians appeared to be possible to transfer from current SmPCs to CDSSs. However, inconsistencies in the SmPC information have to be reduced to enhance their utility.
AIMS: Relevant and easily accessible drug information at point-of-care is essential for physicians' decision making when prescribing. However, the information available by using Clinical Decision Support Systems (CDSSs) often does not meet physicians' requirements. The Summary of Product Characteristics (SmPC) is statutory information about drugs. However, the current structure, content and format of SmPCs make it difficult to incorporate them into CDSSs and link them to relevant patient information from the Electronic Health Records. The aim of the study was to evaluate the perceived needs for drug information among physicians in Sweden. METHODS: We recruited three focus group discussions with 18 physicians covering different specialities. The information from the groups was combined with a questionnaire administered at the beginning of the group discussions. RESULTS: Physicians reported their needs for knowledge databases at the point of drug prescribing. This included more consistent information about existing and new drugs. They also wished to receive automatically generated alerts for severe drug-drug interactions and adverse effects, and to have functions for calculating glomerular filtration rate to enable appropriate dose adjustments to be made for elderly patients and those with impaired renal function. Additionally, features enhancing electronic communication with colleagues and making drug information more searchable were suggested. CONCLUSIONS: The results from the current study showed the need for knowledge databases which provide consistent information about new and existing drugs. Most of the required information from physicians appeared to be possible to transfer from current SmPCs to CDSSs. However, inconsistencies in the SmPC information have to be reduced to enhance their utility.
Authors: P Bastholm Rahmner; E Andersén-Karlsson; T Arnhjort; M Eliasson; L L Gustafsson; L Jacobsson; M L Ovesjö; U Rosenqvist; S Sjöviker; G Tomson; I Holmström Journal: Int J Health Care Qual Assur Inc Leadersh Health Serv Date: 2004
Authors: Jonathan M Teich; Jerome A Osheroff; Eric A Pifer; Dean F Sittig; Robert A Jenders Journal: J Am Med Inform Assoc Date: 2005-03-31 Impact factor: 4.497
Authors: Gilad J Kuperman; Anne Bobb; Thomas H Payne; Anthony J Avery; Tejal K Gandhi; Gerard Burns; David C Classen; David W Bates Journal: J Am Med Inform Assoc Date: 2006-10-26 Impact factor: 4.497
Authors: Ross Koppel; Joshua P Metlay; Abigail Cohen; Brian Abaluck; A Russell Localio; Stephen E Kimmel; Brian L Strom Journal: JAMA Date: 2005-03-09 Impact factor: 56.272
Authors: Marie Eliasson; Pia Bastholm; Peter Forsberg; Kjell Henriksson; Lennart Jacobson; Anders Nilsson; Lars L Gustafsson Journal: Eur J Clin Pharmacol Date: 2006-03-22 Impact factor: 2.953
Authors: Anders Helldén; Fadiea Al-Aieshy; Pia Bastholm-Rahmner; Ulf Bergman; Lars L Gustafsson; Hans Höök; Susanne Sjöviker; Anders Söderström; Ingegerd Odar-Cederlöf Journal: BMJ Open Date: 2015-07-06 Impact factor: 2.692
Authors: Dajana Roshi; Genc Burazeri; Peter Schröder-Bäck; Ervin Toçi; Salvatore Italia; Alban Ylli; Helmut Brand Journal: Front Public Health Date: 2020-08-11
Authors: Lisette Vromans; Gerardine Doyle; Silvia Petak-Opel; Alexander Rödiger; Martina Röttgermann; Elke Schlüssel; Eva Stetter Journal: BMJ Open Date: 2013-08-21 Impact factor: 2.692